Applying Natural Language Processing to ClinicalTrials.gov: mRNA cancer vaccine case study

Abstract Recently, biotechnology and pharmaceutical industries have made strides to adopt and implement Natural Language Processing (NLP) to address challenges faced when extracting and synthesizing high volumes of information found in unstructured and semistructured text. Here we present, and provide a summary of the findings from, a use case where NLP and text mining methodologies were used to extract clinical trial data from ClinicalTrials.gov for mRNA cancer vaccines..

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:16

Enthalten in:

Clinical and Translational Science - 16(2023), 12, Seite 2417-2420

Sprache:

Englisch

Beteiligte Personen:

Bianca Vora [VerfasserIn]
Denison Kuruvilla [VerfasserIn]
Chloe Kim [VerfasserIn]
Michael Wu [VerfasserIn]
Colby S. Shemesh [VerfasserIn]
Gillie A. Roth [VerfasserIn]

Links:

doi.org [kostenfrei]
doaj.org [kostenfrei]
doi.org [kostenfrei]
Journal toc [kostenfrei]
Journal toc [kostenfrei]

Themen:

Public aspects of medicine
Therapeutics. Pharmacology

doi:

10.1111/cts.13648

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

DOAJ099278073